← All trials
NCT04492033
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 22, 2020
- Primary completion
- May 7, 2021
- Completion date
- May 7, 2022
- First posted
- Jul 30, 2020
- Last posted
- Jul 30, 2020
- Enrollment
- 18
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Handok Pharmaceuticals Co., Ltd.Lead sponsor
- National OncoVentureCollaborator
- ABL Bio Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.